<bill session="116" type="h" number="1344" updated="2022-11-01T16:32:52Z">
  <state datetime="2019-02-25">REFERRED</state>
  <status>
    <introduced datetime="2019-02-25"/>
  </status>
  <introduced datetime="2019-02-25"/>
  <titles>
    <title type="display">Competitive DRUGS Act of 2019</title>
    <title type="official" as="introduced">To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes.</title>
    <title type="short" as="introduced">Competitive Deals Resulting in Unleashed Generics and Savings Act of 2019</title>
    <title type="short" as="introduced">Competitive DRUGS Act of 2019</title>
  </titles>
  <sponsor bioguide_id="D000399"/>
  <cosponsors>
    <cosponsor bioguide_id="B000574" joined="2019-02-25"/>
    <cosponsor bioguide_id="C001090" joined="2019-02-25"/>
    <cosponsor bioguide_id="C001080" joined="2019-02-25"/>
    <cosponsor bioguide_id="C000984" joined="2019-02-25"/>
    <cosponsor bioguide_id="D000216" joined="2019-02-25"/>
    <cosponsor bioguide_id="D000623" joined="2019-02-25"/>
    <cosponsor bioguide_id="G000559" joined="2019-02-26"/>
    <cosponsor bioguide_id="G000551" joined="2019-02-25"/>
    <cosponsor bioguide_id="H001087" joined="2019-02-25"/>
    <cosponsor bioguide_id="K000009" joined="2019-02-25"/>
    <cosponsor bioguide_id="K000389" joined="2019-02-25"/>
    <cosponsor bioguide_id="L000559" joined="2019-02-25"/>
    <cosponsor bioguide_id="M001160" joined="2019-02-25"/>
    <cosponsor bioguide_id="N000179" joined="2019-02-25"/>
    <cosponsor bioguide_id="N000147" joined="2019-02-25"/>
    <cosponsor bioguide_id="O000172" joined="2019-02-25"/>
    <cosponsor bioguide_id="P000597" joined="2019-02-25"/>
    <cosponsor bioguide_id="P000607" joined="2019-02-25"/>
    <cosponsor bioguide_id="P000618" joined="2019-02-26"/>
    <cosponsor bioguide_id="W000187" joined="2019-02-25"/>
    <cosponsor bioguide_id="W000800" joined="2019-02-25"/>
  </cosponsors>
  <actions>
    <action datetime="2019-02-25">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-02-25" state="REFERRED">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2019-02-25">
      <text>Referred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2019-02-25">
      <text>Referred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2019-02-25">
      <text>Referred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2019-02-26">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2019-03-25">
      <text>Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSJU" name="House Judiciary" subcommittee="" activity="Referral"/>
    <committee code="HSJU05" name="House Judiciary" subcommittee="Administrative State, Regulatory Reform, and Antitrust" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
    <committee code="HSWM02" name="House Ways and Means" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="h" number="2375" relation="unknown"/>
    <bill session="116" type="s" number="64" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative remedies"/>
    <term name="Business expenses"/>
    <term name="Civil actions and liability"/>
    <term name="Competition and antitrust"/>
    <term name="Federal Trade Commission (FTC)"/>
    <term name="Income tax deductions"/>
    <term name="Intellectual property"/>
    <term name="Judicial review and appeals"/>
    <term name="Marketing and advertising"/>
    <term name="Prescription drugs"/>
    <term name="Research and development"/>
    <term name="Tax administration and collection, taxpayers"/>
  </subjects>
  <amendments/>
  <summary date="2021-09-12T14:48:44Z" status="Introduced in House">Competitive Deals Resulting in Unleashed Generics and Savings Act of 2019 or the Competitive DRUGS Act of 2019

This bill authorizes the Federal Trade Commission to initiate a proceeding against parties to an agreement resolving or settling a patent infringement claim in connection with the sale of a drug.Such an agreement is generally presumed to be an unfair method of competition and is a violation of this bill if the filer of the generic drug application receives something of value and agrees to limit or forgo research, development, manufacturing, marketing, or sales of the generic drug.

However, an agreement is exempted if the only consideration granted to the generic manufacturer is (1) the right to market the generic drug prior to the expiration of any statutory exclusivity, (2) a payment for reasonable litigation expenses, or (3) a covenant not to sue on a claim that the generic drug infringes a patent. An agreement if also exempt if the agreement's pro-competitive benefits outweigh its anticompetitive effects.

The bill establishes penalties for violations of the bill.</summary>
</bill>
